Bali Muralidhar - Net Worth and Insider Trading
Bali Muralidhar Net Worth
The estimated net worth of Bali Muralidhar is at least $5 Million dollars as of 2024-11-10. Bali Muralidhar is the Director of Reneo Pharmaceuticals Inc and owns about 207,396 shares of Reneo Pharmaceuticals Inc (RPHM) stock worth over $4 Million. Bali Muralidhar is the Director of Spruce Biosciences Inc and owns about 1,792,518 shares of Spruce Biosciences Inc (SPRB) stock worth over $960,431. Bali Muralidhar is also the Director of Exicure Inc and owns about 56,327 shares of Exicure Inc (XCUR) stock worth over $154,899. Details can be seen in Bali Muralidhar's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Bali Muralidhar has not made any transactions after 2022-05-19 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Bali Muralidhar
Bali Muralidhar Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Bali Muralidhar owns 3 companies in total, including Spruce Biosciences Inc (SPRB) , Exicure Inc (XCUR) , and Reneo Pharmaceuticals Inc (RPHM) .
Click here to see the complete history of Bali Muralidhar’s form 4 insider trades.
Insider Ownership Summary of Bali Muralidhar
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SPRB | Spruce Biosciences Inc | 2020-10-14 | director |
| XCUR | Exicure Inc | 2022-05-19 | director |
| RPHM | Reneo Pharmaceuticals Inc | 2021-07-14 | director |
Bali Muralidhar Latest Holdings Summary
Bali Muralidhar currently owns a total of 3 stocks. Among these stocks, Bali Muralidhar owns 207,396 shares of Reneo Pharmaceuticals Inc (RPHM) as of July 14, 2021, with a value of $4 Million and a weighting of 77.19%. Bali Muralidhar owns 1,792,518 shares of Spruce Biosciences Inc (SPRB) as of October 14, 2020, with a value of $960,431 and a weighting of 19.64%. Bali Muralidhar also owns 56,327 shares of Exicure Inc (XCUR) as of May 19, 2022, with a value of $154,899 and a weighting of 3.17%.
Latest Holdings of Bali Muralidhar
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| RPHM | Reneo Pharmaceuticals Inc | 2021-07-14 | 207,396 | 18.20 | 3,774,607 |
| SPRB | Spruce Biosciences Inc | 2020-10-14 | 1,792,518 | 0.54 | 960,431 |
| XCUR | Exicure Inc | 2022-05-19 | 56,327 | 2.75 | 154,899 |
Holding Weightings of Bali Muralidhar
Bali Muralidhar Form 4 Trading Tracker
According to the SEC Form 4 filings, Bali Muralidhar has made a total of 6 transactions in Reneo Pharmaceuticals Inc (RPHM) over the past 5 years, including 6 buys and 0 sells. The most-recent trade in Reneo Pharmaceuticals Inc is the acquisition of 11,174 shares on July 14, 2021, which cost Bali Muralidhar around $949,756.
According to the SEC Form 4 filings, Bali Muralidhar has made a total of 1 transactions in Spruce Biosciences Inc (SPRB) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Spruce Biosciences Inc is the acquisition of 200,000 shares on October 14, 2020, which cost Bali Muralidhar around $3 Million.
According to the SEC Form 4 filings, Bali Muralidhar has made a total of 2 transactions in Exicure Inc (XCUR) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Exicure Inc is the acquisition of 9,814 shares on May 19, 2022, which cost Bali Muralidhar around $279,704.
Insider Trading History of Bali Muralidhar
- 1
Bali Muralidhar Trading Performance
GuruFocus tracks the stock performance after each of Bali Muralidhar's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Bali Muralidhar is -17.92%. GuruFocus also compares Bali Muralidhar's trading performance to market benchmark return within the same time period. The performance of stocks bought by Bali Muralidhar within 3 months outperforms 1 times out of 9 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Bali Muralidhar's insider trading performs compared to the benchmark.
Performance of Bali Muralidhar
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -4.9 | | | | | |
| Relative Return to S&P 500(%) | -6.49 | | | | | |
Bali Muralidhar Ownership Network
Ownership Network List of Bali Muralidhar
Ownership Network Relation of Bali Muralidhar
Bali Muralidhar Owned Company Details
What does Spruce Biosciences Inc do?
Who are the key executives at Spruce Biosciences Inc?
Bali Muralidhar is the director of Spruce Biosciences Inc. Other key executives at Spruce Biosciences Inc include 10 percent owner Novo Holdings A/s , Chief Medical Officer Charlton Ralph William Iii , and director & Chief Executive Officer Javier B. Szwarcberg .
Spruce Biosciences Inc (SPRB) Insider Trades Summary
Over the past 18 months, Bali Muralidhar made no insider transaction in Spruce Biosciences Inc (SPRB). Other recent insider transactions involving Spruce Biosciences Inc (SPRB) include a net sale of 4,172,336 shares made by Novo Holdings A/s ,
In summary, during the past 3 months, insiders sold 0 shares of Spruce Biosciences Inc (SPRB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 4,172,336 shares of Spruce Biosciences Inc (SPRB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 4,172,336 shares.
Spruce Biosciences Inc (SPRB)'s detailed insider trading history can be found in Insider Trading Tracker table.
Spruce Biosciences Inc Insider Transactions
Bali Muralidhar Mailing Address
Above is the net worth, insider trading, and ownership report for Bali Muralidhar. You might contact Bali Muralidhar via mailing address: C/o Exicure, Inc., 8045 Lamon Avenue, Suite 410, Skokie Il 60077.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
